Conscience Pause

Conscience Pause More hot air from scientists who persist in believing that they are "special" and deserve special rights.1 Sigh ... This has nothing to do with the public interest or the "sophistication of the scientific method;" rather, it is an expression of status anxiety in a group of people who, not so long ago (say, in the 1950s) were still notables but of late have become proletarianized. Specifically, if egregious violations of public health and safety rules are noticed by an emplo

Written byOlivier Lefevre
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

More hot air from scientists who persist in believing that they are "special" and deserve special rights.1 Sigh ...

This has nothing to do with the public interest or the "sophistication of the scientific method;" rather, it is an expression of status anxiety in a group of people who, not so long ago (say, in the 1950s) were still notables but of late have become proletarianized. Specifically, if egregious violations of public health and safety rules are noticed by an employee who later becomes a whistleblower (such as Francis Doussal in France) and isn't protected, why do scientists deserve special status? Why should a scientist enjoy protection but not, say, a clerk or a foreman? This is obscene. All this special pleading is becoming rather annoying.

Olivier Lefevre, PhD
Bioinformatics Group
Biocrates Life Sciences
Innsbruck, Austria
lefevre@acm.org

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies